Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (91-100 of 522) with videos related to

Pageof 53
Sort By:
Urologic Oncology|July 4, 2009
Candidate quality of care indicators for localized bladder cancerMatthew R Cooperberg, Michael P Porter, Badrinath R Konety
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Time trends and local variation in primary treatment of localized prostate cancerMatthew R Cooperberg, Jeanette M Broering, Peter R Carroll
Current Oncology Reports|March 30, 2016
Clinical Utility of Biomarkers in Localized Prostate CancerMichael S Leapman, Hao G Nguyen, Matthew R Cooperberg
Current Opinion in Urology|March 12, 2014
Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancerChristopher J Welty, Matthew R Cooperberg, Peter R Carroll
JAMA Oncology|November 17, 2022
Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer-ReplyNeal D Shore, Matthew R Cooperberg, Scott A Tomlins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
Androgen deprivation therapy and cardiovascular riskSanoj Punnen, Matthew R Cooperberg, Natalia Sadetsky, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Expression of <i>ACE2,</i> the SARS-CoV-2 receptor, and <i>TMPRSS2</i> in prostate epithelial cellsHanbing Song, Bobak Seddighzadeh, Matthew R Cooperberg, et al.
European Urology|May 19, 2020
Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial CellsHanbing Song, Bobak Seddighzadeh, Matthew R Cooperberg, et al.
BJU International|October 18, 2011
Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?Sanoj Punnen, Matthew R Cooperberg, Natalia Sadetsky, et al.
World Journal of Urology|March 29, 2008
High-risk prostate cancer in the United States, 1990-2007Matthew R Cooperberg, Janet Cowan, Jeannette M Broering, et al.
Pageof 53

Showing results (91-100 of 522) with videos related to

Sort By:
Pageof 53
Urologic Oncology|July 4, 2009
Candidate quality of care indicators for localized bladder cancerMatthew R Cooperberg, Michael P Porter, Badrinath R Konety
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Time trends and local variation in primary treatment of localized prostate cancerMatthew R Cooperberg, Jeanette M Broering, Peter R Carroll
Current Oncology Reports|March 30, 2016
Clinical Utility of Biomarkers in Localized Prostate CancerMichael S Leapman, Hao G Nguyen, Matthew R Cooperberg
Current Opinion in Urology|March 12, 2014
Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancerChristopher J Welty, Matthew R Cooperberg, Peter R Carroll
JAMA Oncology|November 17, 2022
Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer-ReplyNeal D Shore, Matthew R Cooperberg, Scott A Tomlins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2011
Androgen deprivation therapy and cardiovascular riskSanoj Punnen, Matthew R Cooperberg, Natalia Sadetsky, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Expression of <i>ACE2,</i> the SARS-CoV-2 receptor, and <i>TMPRSS2</i> in prostate epithelial cellsHanbing Song, Bobak Seddighzadeh, Matthew R Cooperberg, et al.
European Urology|May 19, 2020
Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial CellsHanbing Song, Bobak Seddighzadeh, Matthew R Cooperberg, et al.
BJU International|October 18, 2011
Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?Sanoj Punnen, Matthew R Cooperberg, Natalia Sadetsky, et al.
World Journal of Urology|March 29, 2008
High-risk prostate cancer in the United States, 1990-2007Matthew R Cooperberg, Janet Cowan, Jeannette M Broering, et al.
Pageof 53